June 8, 2017August 24, 2022
Omadacycline Shows Punch Against Drug-Resistant Bacteria, Studies Indicate

The antibiotic omadacycline has displayed an ability to fight treatment-resistant respiratory, skin and urinary-tract bacteria in preclinical-trial studies, according to its maker, ... Read more
June 6, 2017June 6, 2017
Salvecin and Antibiotics Combo Eradicates Pneumonia Better Than Antibiotics Alone, Phase 2a Trial Shows

A combination of Salvecin (AR-301) and antibiotics eradicated ventilator-associated bacterial pneumonia (VABP) better than antibiotics alone, according to a Phase ... Read more
June 1, 2017June 1, 2017
PPV23 Vaccine’s Effectiveness Against Community-acquired Pneumonia Not Yet Consistent, Researchers Say

The PPV23 vaccine, designed to protect against community-acquired pneumonia (CAP) caused by Streptococcus pneumoniae, is not uniformly effective among the general ... Read more
May 30, 2017May 30, 2017
Triple-Antibiotic Combos Eliminate Two Treatment-Resistant Bacteria

A combination of three antibiotics can eradicate two of today’s six most treatment-resistant bacteria, according to researchers at the State University ... Read more
May 25, 2017May 25, 2017
Adapting Safety, Hygiene Protocols Prevents Pneumonia, Other Ventilator-Associated Illnesses in Hospital ICUs

A new study urges hospital intensive care units (ICUs) to adopt safety and hygiene protocols to reduce the occurrence of ... Read more
May 23, 2017May 23, 2017
Initial Antibiotic Treatment Fails in Nearly One in Four Pneumonia Patients, Study Finds

An initial antibiotics regimen fails to cure pneumonia in one in four patients who acquire the disease outside hospitals and ... Read more
May 18, 2017May 18, 2017
Memory T-Cells Contribute to Body’s Naturally Acquired Immunity Against Pneumonia During Childhood, Study Suggests

A key immune system component called memory T-cells contributes to the naturally occurring protection against pneumonia-causing bacteria that the body develops ... Read more
May 16, 2017May 16, 2017
Risk of Heart Attack Increases 17 Times in Week Following Respiratory Infection

The risk of having a heart attack increases 17 times in the seven days after a respiratory infection, including pneumonia, ... Read more
May 11, 2017May 11, 2017
Respiratory Disease App to Be Evaluated by Doctors Without Borders in Low-income Rural Areas

Doctors Without Borders will conduct a clinical study on ResApp Health‘s respiratory disease app ResAppDx in a lower-income rural setting, the ... Read more
May 9, 2017May 9, 2017
PaxVax Updating 30-Year-Old Vaccine Against Pneumonia Virus That Can Hit Military Recruits

PaxVax is modernizing a pneumonia virus vaccine that hasn’t been updated in 30 years, partly to help protect military recruits. Because ... Read more
May 4, 2017May 4, 2017
T-Follicular Helper Cells Critical in Protecting Against Pneumococcal Pneumonia, Australian Study Shows

T-follicular helper cells generate antibodies that prevent people from getting pneumococcal pneumonia, according to a Australian study whose findings offer important ... Read more
May 2, 2017May 2, 2017
Penicillin-G/V May Reduce Pneumonia Severity and Mortality, Study Suggests

Patients with community-acquired pneumonia (CAP) and treated with penicillin-G/V had less severe pneumonia than patients treated with broad-spectrum antibiotics or ... Read more

May 19, 2016May 19, 2016

Bayer Terminates Riociguat Trial for PH Associated with Idiopathic Interstitial Pneumonias Due to Adverse Events

Bayer recently announced that the company will immediately terminate its Phase 2 clinical trial of riociguat in patients with pulmonary hypertension associated with idiopathic interstitial pneumonias (PH-IIP), following the recommendation of an independent Data Monitoring ... Read more

May 18, 2016May 18, 2016

Risk Groups Account for Large Part of Pneumonia, Pneumococcal Disease Cases

People with certain chronic medical conditions represent a disproportionately large part of all invasive pneumococcal disease and pneumonia cases, with high associated care costs. Particularly, individuals with asthma and diabetes are ... Read more

May 17, 2016May 17, 2016

Pneumonia Vaccination Gets Boost with 2-Minute Video from Northwestern Medicine Researchers

Results from a Northwestern Medicine study showed that a two-minute video concerning pneumococcal vaccination sent to patients before a primary care appointment tripled the likelihood of patients getting the vaccine. The vaccination ... Read more

May 16, 2016May 16, 2016

New Study Emphasizes Importance of Pneumonia Vaccine in Celiac Disease Patients

Patients with celiac disease who did not receive the pneumococcal vaccine are at high risk of getting pneumonia, according to the study, “The risk of community acquired pneumonia among 9,803 patients with ... Read more

May 13, 2016May 20, 2016

Phase 3 Trial Data on Pneumonia Drug Telavancin Presented by Theravance Biopharma

Ireland-based Theravance Biopharma presented new data on Vibativ (telavancin) for the treatment of pneumonia at the American Thoracic Society’s International Conference May 13-18 in in San Francisco. The poster-presentation data, titled “Clinical Efficacy and ... Read more

May 12, 2016May 20, 2016

Risk Factors for Pneumonia Identified in Large Taiwan Population of Parkinson’s Patients

A large Taiwan population-based cohort study identified several risk factors, including chronic heart failure, chronic kidney disease, and tooth decay, associated with increased hospitalization of Parkinson’s disease patients due to pneumonia. The ... Read more

May 11, 2016May 12, 2016

Resistant Staphylococcus aureus Causing Community-acquired Pneumonia Needs Novel Diagnostics Strategy, Study Shows

In a new study, researchers highlighted the need for new diagnostic strategies to effectively distinguish between susceptible and resistant Staphylococcus aureus causing community-acquired pneumonia (CAP), so that effective antibiotic therapies are properly ... Read more

May 10, 2016May 10, 2016

A Blanket for Incubator Tubes Helps Premature Babies Survive

Researchers from a start-up company called Vincent’s Solutions, based at the University of California (UC) Merced, have developed a special blanket – not to help babies sleep – but to ... Read more

May 9, 2016May 9, 2016

New Study Shows Aspiration Pneumonia Leads to Longer and Costlier Hospitalizations in Children

Researchers at Boston Children’s Hospital recently compared the clinical and hospitalization outcomes in children with aspiration pneumonia and with community-acquired pneumonia, and found that children with aspiration pneumonia are more likely to have ... Read more

May 6, 2016May 6, 2016

CHMP Favors EU Approval of CAZ AVI Antibiotic to Treat Serious Bacterial Infections

The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion recommending the approval of CAZ AVI 2g/0.5g formulation for the ... Read more

May 5, 2016May 6, 2016

Quick and Easy Molecular Test for Mycoplasma pneumoniae Approved for European Use

Meridian Bioscience announced that the company’s new, simplified, and rapid molecular diagnostic test for Mycoplasma pneumoniae has received the CE Mark, allowing for the product to be legally placed on the European ... Read more

May 4, 2016May 4, 2016

NDA Submission Complete for Bacterial Pneumonia Treatment of Solithromycin, Cempra Announces

Cempra Inc. announced it has completed submissions to the U.S. Food and Drug Administration (FDA) of a New Drug Application (NDA) for its lead product candidate solithromycin for the treatment of ... Read more

Omadacycline Shows Punch Against Drug-Resistant Bacteria, Studies Indicate

Salvecin and Antibiotics Combo Eradicates Pneumonia Better Than Antibiotics Alone, Phase 2a Trial Shows

PPV23 Vaccine’s Effectiveness Against Community-acquired Pneumonia Not Yet Consistent, Researchers Say

Triple-Antibiotic Combos Eliminate Two Treatment-Resistant Bacteria

Adapting Safety, Hygiene Protocols Prevents Pneumonia, Other Ventilator-Associated Illnesses in Hospital ICUs

Initial Antibiotic Treatment Fails in Nearly One in Four Pneumonia Patients, Study Finds

Memory T-Cells Contribute to Body’s Naturally Acquired Immunity Against Pneumonia During Childhood, Study Suggests

Risk of Heart Attack Increases 17 Times in Week Following Respiratory Infection

Respiratory Disease App to Be Evaluated by Doctors Without Borders in Low-income Rural Areas

PaxVax Updating 30-Year-Old Vaccine Against Pneumonia Virus That Can Hit Military Recruits

T-Follicular Helper Cells Critical in Protecting Against Pneumococcal Pneumonia, Australian Study Shows

Penicillin-G/V May Reduce Pneumonia Severity and Mortality, Study Suggests